Optalert developed the world’s leading algorithm to quantify the deterioration in cognitive brain function due to drowsiness and created the Johns Drowsiness Scale (JDS) which remains the only scientifically proven, objective measurement of drowsiness.
The JDS is used worldwide in research for accurately quantifying drowsiness levels, and in Optalert’s early-warning drowsiness detection systems to protect thousands of lives and valuable company assets across multiple industries. Our clients include BHP Billiton, Vale and NASA. Our research partners include the Harvard Medical School, Monash University, and the University of Queensland.
Optalert is a Medical Technology company pioneering the use of Blepharometry (the measurement of blinks) to measure drowsiness. Optalert discovered a key biomarker for drowsiness, the connection between brain function and eyelid movement.
Optalert is now turning its extensive expertise in Blepharometry and Artificial Intelligence to identify the biomarkers for other degradations to neurological brain function in conditions such as Epilepsy (due to onset of seizures), ADHD, Parkinson’s, Alzheimer’s, TBI, concussion and motor neuron disease.
The JDS is used worldwide in research for accurately quantifying drowsiness levels, and in Optalert’s early-warning drowsiness detection systems to protect thousands of lives and valuable company assets across multiple industries. Our clients include BHP Billiton, Vale and NASA. Our research partners include the Harvard Medical School, Monash University, and the University of Queensland.
Optalert is a Medical Technology company pioneering the use of Blepharometry (the measurement of blinks) to measure drowsiness. Optalert discovered a key biomarker for drowsiness, the connection between brain function and eyelid movement.
Optalert is now turning its extensive expertise in Blepharometry and Artificial Intelligence to identify the biomarkers for other degradations to neurological brain function in conditions such as Epilepsy (due to onset of seizures), ADHD, Parkinson’s, Alzheimer’s, TBI, concussion and motor neuron disease.
Location: Australia, Victoria, Melbourne
Employees: 11-50
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Exto Partn... | extopartne... |
Mentions in press and media 3
| Date | Title | Description |
| 05.02.2025 | Aussie sleeptech firm unveils breakthrough test | MELBOURNE, Australia, Feb. 5, 2025 /PRNewswire/ -- Australian medical technology company Optalert has revealed a breakthrough test for sleep issues, expanding access to sleep health technologies for millions of Australians. The simple test ... |
| 15.12.2016 | How are car manufacturers integrating biometrics into vehicles to monitor health? | The report draws attention to security enhancements like fingerprint, voice and iris recognition as well as medical monitoring of heart beats, brain waves, face, fatigue and eyelids, and pulse detection. The technology enabling these capabi... |
| - | How are car manufacturers integrating biometrics into vehicles to monitor health? | Ford ‘s Automotive Wearables Experience lab at its Research and Innovation Center in Dearborn, Michigan. Some terrible accidents have called attention to some of the risks when people with an underlying medical conditions get into the drive... |